Comparative Pharmacology
Head-to-head clinical analysis: COLYTE WITH FLAVOR PACKS versus SUTAB.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COLYTE WITH FLAVOR PACKS versus SUTAB.
COLYTE WITH FLAVOR PACKS vs SUTAB
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Colyte is an isotonic solution containing polyethylene glycol 3350 and electrolytes. It acts as an osmotic laxative by retaining water in the colon through non-absorbable polyethylene glycol, resulting in bowel evacuation. The electrolytes prevent significant fluid and electrolyte shifts.
SUTAB is a combination tablet consisting of sodium sulfate, magnesium sulfate, and potassium chloride. It acts as an osmotic laxative by drawing water into the bowel lumen through the osmotic effect of sulfate ions, inducing colonic evacuation. Additionally, magnesium ions enhance this effect by attracting water via osmotic pressure and stimulating the release of cholecystokinin, which promotes peristalsis.
Adults: 4 liters of reconstituted solution administered orally or via nasogastric tube at a rate of 240 mL every 10 minutes, given as a single dose or in divided doses for colonoscopy preparation.
24 tablets administered as 4 tablets every 15 minutes, total dose of 17.5 g sodium sulfate, 3.13 g magnesium sulfate, and 1.64 g potassium sulfate, orally, with water, the evening before colonoscopy.
None Documented
None Documented
Not applicable (non-absorbed; no systemic absorption, thus no elimination half-life in plasma).
Terminal elimination half-life: 6-8 hours in adults with normal renal function; prolonged to 20-40 hours in end-stage renal disease.
Primarily fecal (100%) as non-absorbed oral solution; negligible renal or biliary elimination.
Primarily renal excretion (65-75% unchanged) with minor biliary/fecal elimination (<10%). Total body clearance approximates renal blood flow.
Category C
Category C
Osmotic Laxative
Osmotic Laxative